Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonreplicating vaccinia vector efficiently expresses recombinant genes.

G Sutter1, B Moss

  • 1Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.

Proceedings of the National Academy of Sciences of the United States of America
|November 15, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of the monkeypox virus genome.

Virology·2002
Same author

Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.

Cancer research·2001
Same author

Oligomeric structure of virion-associated and soluble forms of the simian immunodeficiency virus envelope protein in the prefusion activated conformation.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

Human monkeypox and smallpox viruses: genomic comparison.

FEBS letters·2001
Same author

High-speed mass transit for poxviruses on microtubules.

Nature cell biology·2001
Same author

Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails.

Journal of virology·2001
Same journal

Chemotactic self-organization captures the dynamics of mammalian hair follicle patterning.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Tomographic imaging of superconducting order using particle-hole interference.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoir.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Inferring epidemiological parameters under an infectious phylogeography model with visitor dynamics.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Analytical modeling for suction cup designs for skin-interfaced wearable devices.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Improving cell-free metabolism through direct integration of artificial respiratory chains.

Proceedings of the National Academy of Sciences of the United States of America·2026
See all related articles

Modified vaccinia Ankara (MVA) can serve as a safe and effective gene expression vector. Despite limited replication in human cells, MVA successfully expresses foreign genes, showing potential for advanced biotechnology applications.

Area of Science:

  • Virology
  • Molecular Biology
  • Biotechnology

Background:

  • Modified vaccinia Ankara (MVA) is a highly attenuated vaccinia virus strain with a proven safety record in human trials.
  • MVA exhibits severe host cell restriction, replicating efficiently in avian cells but not in most mammalian cells, including human cells.
  • Despite restricted replication, MVA supports viral DNA replication and synthesis of viral proteins in human cells.

Purpose of the Study:

  • To evaluate the potential of Modified vaccinia Ankara (MVA) as a safe and efficient gene expression vector.
  • To construct and characterize MVA recombinants expressing a foreign gene (lacZ) in non-permissive human cells.

Main Methods:

  • Construction of an insertion plasmid containing the Escherichia coli lacZ gene under the MVA P11 late promoter.

Related Experiment Videos

  • Homologous recombination was used to insert the lacZ gene into a specific deletion site within the MVA genome.
  • Isolation and propagation of MVA recombinants in permissive avian cells, followed by infection of non-permissive human cells.

    • Main Results:

    • MVA recombinants were successfully generated and propagated in avian cells.
    • Infection of non-permissive human cells with MVA recombinants resulted in the expression of beta-galactosidase.
    • The level of beta-galactosidase expression in human cells was comparable to that produced by a recombinant Western Reserve vaccinia virus.

    Conclusions:

    • Recombinant gene expression is not impaired in non-permissive human cells despite MVA's limited replication.
    • Modified vaccinia Ankara (MVA) demonstrates potential as a highly efficient and exceptionally safe gene expression vector.
    • MVA's unique properties make it a promising candidate for biotechnological applications requiring safe gene delivery.